Lung CancerConnect
Screening - Prevention & Early Detection of Lung Cancer
Who is at risk of developing lung cancer? New lung cancer screening guidelines updated - July 2020.
How Should Oligometastatic NSCLC be Treated?
Local ablative treatment combined with immunotherapy improves long term survival in oligometastatic NSCLC.
Keytruda Doubles Survival Compared to Chemotherapy Treatment of NSCLC
Keytruda is the standard of care for PD-1 + NSCLC. Longer follow continues to confirm advantage over chemotherapy.
Lung Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. Lung Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Lung Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. Lung Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Lung Cancer Overviews
Screening - Prevention & Early Detection of Lung Cancer
Who is at risk of developing lung cancer? New lung cancer screening guidelines updated - July 2020.
Treatment of Stage I - IIIA Non-Small Cell Lung Cancer
Update on the management of early stage NSCLC: precision medicines & immunotherapy changing the treatment landscape.
Patients With NSCLC Are Not Undergoing Biomarker Testing for Precision Medicines
Patients With NSCLC Are Not Undergoing Biomarker Testing for Precision Medicines-Patient Education is Key
Treatment & Management of Non Small Cell Lung Cancer
Understand the role of precision cancer medicine, surgery, chemotherapy and radiation in the management of NSCLC.
Lung Cancer Treatment & Management
How Should Oligometastatic NSCLC be Treated?
Local ablative treatment combined with immunotherapy improves long term survival in oligometastatic NSCLC.
Keytruda Doubles Survival Compared to Chemotherapy Treatment of NSCLC
Keytruda is the standard of care for PD-1 + NSCLC. Longer follow continues to confirm advantage over chemotherapy.
Treatment of Stage I - IIIA Non-Small Cell Lung Cancer
Update on the management of early stage NSCLC: precision medicines & immunotherapy changing the treatment landscape.
Liquid Biopsy Detects Cancer Progression Much Earlier Than Imaging
What if a simple blood test could quickly determine when cancer treatment was ineffective and prevent its unnecessary use?
Lung Cancer Survivorship
Screening - Prevention & Early Detection of Lung Cancer
Who is at risk of developing lung cancer? New lung cancer screening guidelines updated - July 2020.
Does Air Pollution Cause Lung Cancer?
The WHO classifies air pollution as a carcinogen & ample evidence is emerging on it overall negative health consequences
CancerConnect - November is Lung Cancer Awareness Month
Development of precision cancer medicines, immunotherapy, genomic testing are proceeding with great speed - Stay Current
How Can You Reduce Your Risk of Lung Cancer?
Research suggests the key to avoiding lung cancer is to stop smoking, avoid Radon and eat cruciferous vegetables!